Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in high risk diffuse large cell B-cell lymphoma patients as a first line treatment

Schwarzbich, M.-A.; Schöning, T.; Cremer, M.; Lisenko, K.; Ho, A.D.; Witzens-Harig, M.

Leukemia and Lymphoma 57(7): 1723-1726

2016


ISSN/ISBN: 1029-2403
PMID: 26980422
DOI: 10.3109/10428194.2015.1113274
Accession: 057738642

Download citation:  
Text
  |  
BibTeX
  |  
RIS

Article/Abstract emailed within 0-6 h
Payments are secure & encrypted
Powered by Stripe
Powered by PayPal